2 completed, 1 terminated. 2 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 4 | 1 | Terminated 1 |
Follow Clostridium Difficile-associated Diarrhea (CDAD): new trials by email Literature Review of Clostridium Difficile-associated Diarrhea (CDAD) trials Research Report on Clostridium Difficile-associated Diarrhea (CDAD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD) Fidaxomicin oral suspension, Fidaxomicin tablets, Vancomycin oral liquid - Clostridium Difficile-associated Diarrhea (CDAD) | Phase 3 | Completed | Astellas Pharma Europe B.V. | 148 | 2015-01-09 | 2024-11-26 |
| Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation (MK-5119-001) fidaxomicin, Placebo - Clostridium Difficile-Associated Diarrhea (CDAD) | Phase 3 | Completed | Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 611 | 2012-10-10 | 2018-09-18 |
| IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff intravenous immunoglobulin G (IVIG), Placebo - Clostridium Difficile-associated Diarrhea (CDAD) | Phase 4 | Terminated | University of Pittsburgh | 14 | 2003-10-01 | 2016-10-25 |
Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Gram-Positive Bacterial Infections (1) · Infections (1)
Fidaxomicin (2) · Immunoglobulins, Intravenous (1) · OPT 80 (1) · Vancomycin (1)
Astellas Pharma Europe B.V. (1) · Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1) · University of Pittsburgh (1)
United States (2) · Belgium (1) · Canada (1) · France (1) · Germany (1) · Hungary (1) · Italy (1) · Poland (1) · Romania (1) · Spain (1)